Cargando…

Clinical significance of tryptophan catabolism in Hodgkin lymphoma

Indoleamine 2,3‐dioxygenase 1 (IDO) is an enzyme catabolizing tryptophan (Trp) into the kynurenine (Kyn) pathway. The purpose of the present study was to determine the clinical significance of Trp catabolism in newly diagnosed Hodgkin lymphoma (HL) patients. We quantified serum Trp and Kyn in 52 HL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masaki, Ayako, Ishida, Takashi, Maeda, Yasuhiro, Ito, Asahi, Suzuki, Susumu, Narita, Tomoko, Kinoshita, Shiori, Takino, Hisashi, Yoshida, Takashi, Ri, Masaki, Kusumoto, Shigeru, Komatsu, Hirokazu, Inagaki, Hiroshi, Ueda, Ryuzo, Choi, Ilseung, Suehiro, Youko, Iida, Shinsuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765298/ https://www.ncbi.nlm.nih.gov/pubmed/29080383 http://dx.doi.org/10.1111/cas.13432

Ejemplares similares

Human T‐cell lymphotropic/leukemia virus type 1 (HTLV‐1) Tax‐specific T‐cell exhaustion in HTLV‐1‐infected individuals
por: Masaki, Ayako, et al.
Publicado: (2018)

Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma
por: Kinoshita, Shiori, et al.
Publicado: (2018)

Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma
por: Yoshida, Takashi, et al.
Publicado: (2018)

Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits
por: Yoshida, Takashi, et al.
Publicado: (2018)

Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1
por: Hagiwara, Shinya, et al.
Publicado: (2021)

Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole
por: Yoshida, Takashi, et al.
Publicado: (2019)

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy
por: Kikuchi, Takaki, et al.
Publicado: (2020)

Acute Promyelocytic Leukemia in a Patient With Chronic Continuous Type of Crohn’s Disease
por: Kinoshita, Shiori, et al.
Publicado: (2022)

P820: POTENTIAL IMMUNOSUPPRESSIVE EFFECT OF EXTRACELLULAR VESICLES FROM PATIENTS WITH MULTIPLE MYELOMA
por: Hagiwara, Shinya, et al.
Publicado: (2023)

Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma
por: Tachita, Takuto, et al.
Publicado: (2020)

A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma
por: Fujii, Keiichiro, et al.
Publicado: (2020)

Clinical significance of CD28 gene‐related activating alterations in adult T‐cell leukaemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2020)

Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2021)

Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma
por: Murase, Takayuki, et al.
Publicado: (2019)

Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system
por: Murase, Takayuki, et al.
Publicado: (2019)

Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model
por: Mori, F, et al.
Publicado: (2012)

Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
por: Tanaka, Norio, et al.
Publicado: (2022)

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study
por: Nakayama, Takafumi, et al.
Publicado: (2020)

Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2021)

CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment
por: Sakamoto, Yuma, et al.
Publicado: (2022)

Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
por: Nosaka, Kisato, et al.
Publicado: (2021)

Clinical landscape of TP73 structural variants in ATL patients
por: Hiramatsu, Hiroaki, et al.
Publicado: (2023)

Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy
por: Narita, T, et al.
Publicado: (2015)

The Role of Placental Tryptophan Catabolism
por: Sedlmayr, Peter, et al.
Publicado: (2014)

Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia–lymphoma
por: Hiramatsu, Hiroaki, et al.
Publicado: (2022)

The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib
por: Mori, Yoshinori, et al.
Publicado: (2018)

Lack of Ku80 Alteration in Multiple Myeloma
por: Kato, Miyuki, et al.
Publicado: (2002)

Tryptophan-Catabolizing Enzymes – Party of Three
por: Ball, Helen J., et al.
Publicado: (2014)

Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
por: Munn, David H., et al.
Publicado: (1999)

The therapeutic potential of targeting tryptophan catabolism in cancer
por: Opitz, Christiane A., et al.
Publicado: (2019)

Achromobacter Infection Is Rare in Japanese Patients with Pulmonary B-cell Lymphoma
por: Aoyama, Satsuki, et al.
Publicado: (2017)

Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
por: Mehraj, Vikram, et al.
Publicado: (2015)

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship
por: Bortolotti, Perrine, et al.
Publicado: (2016)

Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease
por: Gulcev, Makedonka, et al.
Publicado: (2016)

Altered Tryptophan Catabolism in Placentas From Women With Pre-eclampsia
por: Keaton, Sarah A, et al.
Publicado: (2019)

Tryptophan catabolism and immune activation in primary and chronic HIV infection
por: Gelpi, Marco, et al.
Publicado: (2017)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
por: Peyraud, Florent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jc0fqtdjelpnbr2f8sm5lrd9so